JAN STERN REED - 22 Dec 2021 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma, by power of attorney
Issuer symbol
RCEL
Transactions as of
22 Dec 2021
Net transactions value
$0
Form type
4
Filing time
27 Dec 2021, 15:30:44 UTC
Previous filing
23 Jul 2021
Next filing
28 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +8,675 8,675 22 Dec 2021 Direct F1, F2
transaction RCEL Common Stock Award +4,350 +50% 13,025 22 Dec 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +4,925 $0.000000 4,925 22 Dec 2021 Common Stock 4,925 $12.18 Direct F4
transaction RCEL Stock Options (Right to Buy) Award $0 +2,550 $0.000000 2,550 22 Dec 2021 Common Stock 2,550 $12.18 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date.
F2 Includes unvested RSUs.
F3 Represents an award of RSUs that vest on the date 12 months following the grant date.
F4 These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date.
F5 These Stock Options vest on the date 12 months following the grant date.